3RD EUROPEAN ASSOCIATION FOR CANCER RESEARCH (EACR) CONFERENCE ON CELL DEATH IN CANCER
De Rode Hoed’s Great HallAMSTERDAM, NETHERLANDS Visit the Venue to read more
The EACR Conference "A Matter of Life or Death: Mechanisms and Relevance of Cell Death for Cancer Biology and Treatment" is the third conference on this topic. Its objective is to cover recent and exciting developments in the field that are crucial to our understanding of the multifaceted role of cell death in tumour initiation, progression and therapy response.
This meeting is of interest to scientists from different fields of cancer research, such as cancer biology, molecular pathology, molecular oncology, cancer immunology, pharmacology, radiation biology and oncology, and medical oncology, as it will cover the multifaceted role of cell death in cancer ranging from basic mechanisms of cell death signalling and resistance, tumour microenvironment, tumour heterogeneity, and immune effects to target discovery and new therapy concepts. Given its translational character, the conference is of broad interest for basic, translational and clinical researchers as well as for companies. We will provide ample opportunities for early stage basic and translational cancer researchers and young medical oncologists to present their work to the international community and to meet experts in the field in an inspiring informal atmosphere to share research findings and to establish or strengthen collaborations.
Download and share
A4 promotional leaflet
Although our understanding of the mechanisms of apoptotic and non-apoptotic programmed cell death modes has increased enormously during the last decade, successful translation of our knowledge into clinical application to the benefit of patients is still challenging. Research about the mechanisms of classical and non-classical modes of programmed cell death, and their dual role in tumour development and therapy response is a rapidly evolving field that has enormous impact on the development and implementation of novel treatment strategies.
Induction of cell death is the molecular basis of the cytotoxic action of many chemotherapeutic drugs and radiotherapy. Conversely, evading programmed cell death has been recognised as one major hallmark of cancer cells thereby contributing to therapy resistance. Cancer cells may even hijack tumour suppressor mechanisms like protective autophagy to survive adverse conditions in the tumour microenvironment. Otherwise, the mode of cell death is also an important determinant of the immune response resulting from therapy-induced tissue damage that may either increase the antitumor effect or be tumour promoting.
Topics to be covered
The various modes of programmed cell death and their regulation, e.g. apoptosis, autophagy and necroptosis;
Cancer cell autonomous TRAIL-receptor signaling and cancer progression;
Ouroborous, autophagy and growth control;
The interplay of p53-mediated apoptosis and tumour suppression;
The protein interaction map of apoptosis and autophagy;
Autophaghy and cancer metabolism;
Importance and therapeutic exploitation of the cellular stress response, the ubiquitin proteasome system and cell death signalling for cancer therapy;
In vivo RNAi screening for the identification of new resistance mechanisms;
Precision cancer therapy targeting mitochondria;
New strategies to kill cancer stem cells;
Therapeutic targets in DNA repair;
Therapeutic reprograming of radiation-induced immune deviation in normal tissue responses.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
De Rode Hoed is a historic building in the picturesque heart of Amsterdam. De Rode Hoed’s Great Hall is the largest and oldest remaining hidden church in the Netherlands and a perfect setting for a meeting and informal open discussion.
The route from to de Rode Hoed from Amsterdam Central Station and nearby parking garages (see below)
1015 CV AMSTERDAM
Travelling to and from the Airport
The train station at Schipol Airport is easily accessed by lifts or escalators in the terminal building. There are very regular trains to the Amsterdam Central Station. Tickets can be purchased from ticket machines using a credit card and we recommend spending a little extra to take the fast route with no stops between the airport and the station. The journey takes less than 15 minutes.
9 proffered papers will be selected from submitted abstracts for oral presentation.
All abstracts will be reviewed by the Scientific Programme Committee and successful delegates will be notified of their poster or oral presentation as soon as possible after the deadline.
Poster specifications: Poster Boards are 1m by 2m in Portrait. Your poster should be no greater than 90cm x 140cm in Portrait. You can attach your poster with drawing pins or double-sided Velcro tape which will be provided for you.
This meeting is of interest to scientists from different fields of cancer research, such as cancer biology,
molecular pathology, molecular oncology, cancer immunology, pharmacology, radiation biology and
oncology, and medical oncology, as it will cover the multifaceted role of cell death in cancer ranging from
basic mechanisms of cell death signalling and resistance, tumour microenvironment, tumour
heterogeneity, and immune effects to target discovery and new therapy concepts. Given its translational
character, the conference is of broad interest for basic, translational and clinical researchers as well as for
We expect around 150 participants. The venue (a converted former church) allows us to accommodate
an exhibition of 7 stands.
Partnership Sponsor with Satellite Presentation: €2,000 (1 available)
Satellite Session for 30 minutes on Friday 29 January
o Promotional support to assist in obtaining good attendance at the Satellite Session, which
includes a detailed announcement in a special promotional email to all conference
o Opportunity to display promotional banners at the front of the main auditorium for the
duration of the Satellite Session
Prime exhibition space within the exhibition area including 1 table and 2 chairs
2 complimentary registrations including Conference Dinner on Friday 29 January. For extra stand
staff please see overleaf.
1 A4 full page colour advertisement in the printed and online Conference Programme Book
Partnership Sponsorship and Satellite Session details highlighted in the printed and online
Conference Programme Book
Company logo and website link featured on conference website
After the conference an updated delegate list will be provided for a single post-conference mailing
This conference is organised by the European Association for Cancer Research as part of the EACR Conference Series.
If you have any queries that are not answered on this website or in the Frequently Asked Questions, please contact us using the details below.
EACR Conference Series Manager
European Association for Cancer Research
Sir Colin Campbell Building
University of Nottingham Innovation Park
Nottingham NG7 2TU
Tel: +44 (0) 115 9515114
Fax: +44 (0) 115 9515115